推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

IMMUNOLOGY LETTERS

2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 IMMUNOL LETT最新评论:请问we大概要多久呀? (2024-07-31)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中国科学院分区:   是否OA期刊:   结果排序:
 
同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


IMMUNOLOGY LETTERS期刊基本信息Hello,您是该期刊的第43188位访客


基本信息 登录收藏
期刊名字IMMUNOLOGY LETTERSIMMUNOLOGY LETTERS

IMMUNOL LETT
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
6.3
50人评分
我要评分

声誉
7.6

影响力
5.1

速度
7.0

期刊ISSN0165-2478
微信扫码收藏此期刊
E-ISSN1879-0542
2023-2024最新影响因子
(数据来源于搜索引擎)
3.3 点击查看影响因子趋势图
实时影响因子 截止2024年10月29日:2.156
2023-2024自引率0.00%点击查看自引率趋势图
五年影响因子3.6
JCI期刊引文指标 0.57
h-index 85
CiteScore
2024年最新版
CiteScoreSJRSNIPCiteScore排名
7.601.0200.786
学科分区排名百分位
大类:Medicine
小类:Immunology and Allergy
Q271 / 233
大类:Medicine
小类:Immunology
Q285 / 236

期刊简介
Immunology Letters provides a vehicle for the speedy publication of experimental papers, (mini)Reviews and Letters to the Editor addressing all aspects of molecular and cellular immunology. The essential criteria for publication will be clarity, experimental soundness and novelty. Results contradictory to current accepted thinking or ideas divergent from actual dogmas will be considered for publication provided that they are based on solid experimental findings.

Preference will be given to papers of immediate importance to other investigators, either by their experimental data, new ideas or new methodology. Scientific correspondence to the Editor-in-Chief related to the published papers may also be accepted provided that they are short and scientifically relevant to the papers mentioned, in order to provide a continuing forum for discussion.
期刊官方网站http://www.journals.elsevier.com/immunology-letters/
期刊投稿网址https://www.editorialmanager.com/IMLET
期刊语言要求Language
Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service.

经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足IMMUNOLOGY LETTERS的语言要求,还能让IMMUNOLOGY LETTERS编辑和审稿人得到更好的审稿体验,让稿件最大限度地被IMMUNOLOGY LETTERS编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问No
通讯方式ELSEVIER SCIENCE BV, PO BOX 211, AMSTERDAM, NETHERLANDS, 1000 AE
出版商Elsevier
涉及的研究方向医学-免疫学
出版国家或地区NETHERLANDS
出版语言Multi-Language
出版周期Monthly
出版年份0
年文章数 85点击查看年文章数趋势图
Gold OA文章占比20.22%
研究类文章占比:
文章 ÷(文章 + 综述)
94.12%
WOS期刊SCI分区
2023-2024年最新版
WOS分区等级:3区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:IMMUNOLOGYSCIEQ395/181
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:IMMUNOLOGYSCIEQ3110/181
中国科学院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中国科学院SCI期刊分区
2023年12月最新升级版
点击查看中国科学院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 2区4区1区
IMMUNOLOGY
免疫学
3区1区4区
中国科学院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 2区3区2区
IMMUNOLOGY
免疫学
2区1区4区
中国科学院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 4区4区3区
IMMUNOLOGY
免疫学
1区3区4区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0165-2478%5BISSN%5D
平均审稿速度网友分享经验:
平均1.0个月
来源Elsevier官网:
平均8.1周
平均录用比例网友分享经验:
约50%
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在IMMUNOLOGY LETTERS顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
在线出版周期来源Elsevier官网:
平均5.5周
期刊常用信息链接
同领域相关期刊 IMMUNOLOGY LETTERS期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 IMMUNOLOGY LETTERS中国科学院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
IMMUNOLOGY LETTERS上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中国科学院分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 中国科学院分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    NATURE REVIEWS IMMUNOLOGY35193.40
    NATURE IMMUNOLOGY34440.00
    Annual Review of Immunology27957.20
    Immunity35549.40
    Cellular & Molecular Immunology6431.20
    TRENDS IN IMMUNOLOGY20925.10
    JOURNAL OF EXPERIMENTAL MEDICINE41126.60
    AUTOIMMUNITY REVIEWS10324.70
    BRAIN BEHAVIOR AND IMMUNITY12729.60
    JOURNAL OF AUTOIMMUNITY10127.90
    中国科学院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE677700
    BIOMATERIALS567285
    BIOMEDICINE & PHARMACOTHERAPY552018
    Frontiers in Pharmacology515786
    Journal of Materials Chemistry B506974
    Frontiers in Immunology492571
    COMPUTERS IN BIOLOGY AND MEDICINE474436
    JOURNAL OF ETHNOPHARMACOLOGY466711
    COLLOIDS AND SURFACES B-BIOINTERFACES438831
    Frontiers in Oncology436521
  •  

    IMMUNOLOGY LETTERS IMMUNOLOGY LETTERS
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.The imbalance of circulating monocyte subgroups with a higher proportion of the CD14+CD16+CD163+phenotype in patients with preeclampsia

    Author: Gong, Fengyan; Wang, Junwei; Lu, Nianhong; Wang, Jiangyuan; Wang, Jia; Shi, Xu; Cui, Miao; Cui, Lifeng
    Journal: IMMUNOLOGY LETTERS. 2023; Vol. 253, Issue , pp. 1-7. DOI: 10.1016/j.imlet.2022.11.005
        PubMed      DOI
    2.The frequencies of lymphocyte subsets on ?day 30?correlate with the clinical outcome of pediatric hematopoietic stem cell transplantation

    Author: Yao, Yanhua; Li, Bohan; Li, Jie; Yao, Di; Ling, Jing; Hu, Yixin; Fan, Liyan; Wan, Lin; Kong, Lingjun; Xiao, Peifang; Lu, Jun; Meng, Lijun; Li, Zhiheng; Hu, Shaoyan; Tian, Yuanyuan
    Journal: IMMUNOLOGY LETTERS. 2023; Vol. 254, Issue , pp. 21-29. DOI: 10.1016/j.imlet.2023.01.009
        PubMed      DOI
    3.Construction of CAR-T cells targeting TM4SF1 and its anti-tumor capacity in ovarian cancer

    Author: Shen, Yijie; Liu, Guodi; Zhang, Qian; Tian, Xiaoli; Ouyang, Liming; Zhang, Lixin
    Journal: IMMUNOLOGY LETTERS. 2023; Vol. 255, Issue , pp. 1-9. DOI: 10.1016/j.imlet.2023.01.011
        PubMed      DOI
    4.TIPE-2 ameliorates inflammatory bowel disease in mice via inhibiting STAT3 and NF-kB activation

    Author: Zhou, Shouzhi; Yang, Zhao; Liu, Jiaxin; Ran, Maojuan
    Journal: IMMUNOLOGY LETTERS. 2023; Vol. 255, Issue , pp. 32-39. DOI: 10.1016/j.imlet.2023.02.005
        PubMed      DOI
    5.Deciphering prognostic value of CD22 and its contribution to suppression of proinflammatory cytokines production in patients with IgA nephropathy

    Author: Liu, Youxia; Li, Hongfen; Yu, Huyan; Wang, Fanghao; Cao, Haiyan; Jia, Junya; Yan, Tiekun
    Journal: IMMUNOLOGY LETTERS. 2023; Vol. 255, Issue , pp. 40-46. DOI: 10.1016/j.imlet.2023.02.007
        PubMed      DOI
    6.Proinflammatory S100A9 stimulates TLR4/NF-?B signaling pathways causing enhanced phagocytic capacity of microglial cells

    Author: Zhang, Xiaoyin; Sun, Dan; Zhou, Xin; Zhang, Ce; Yin, Qing; Chen, Li; Tang, Yong; Liu, Yonggang; Morozova-Roche, Ludmilla A.
    Journal: IMMUNOLOGY LETTERS. 2023; Vol. 255, Issue , pp. 54-61. DOI: 10.1016/j.imlet.2023.02.008
        PubMed      DOI
    7.Serum interleukin-38 and-41 levels as candidate biomarkers in male infertility

    Author: Rong, Chunhao; Weng, Linjie; Li, Mingcai; Zhou, Liming; Li, Yan
    Journal: IMMUNOLOGY LETTERS. 2023; Vol. 255, Issue , pp. 47-53. DOI: 10.1016/j.imlet.2023.02.009
        PubMed      DOI
    8.The role of ocular dendritic cells in uveitis

    Author: Wei Lin, Tingting Liu, Beibei Wang, Hongsheng Bi
    Journal: IMMUNOLOGY LETTERS, 2019, Vol., , DOI:10.1016/j.imlet.2019.03.016
        DOI
    9.Targeting the tumor microenvironment to overcome immune checkpoint blockade therapy resistance

    Author: Yaqi Li, Jing Liu, Long Gao, Yuan Liu, Fang Meng, Xiaoan Li, F. Xiao-Feng Qin
    Journal: IMMUNOLOGY LETTERS, 2019, Vol., , DOI:10.1016/j.imlet.2019.03.006
        DOI
    10.Circulating CXCR3-CCR6-CXCR5+CD4+ T cells are associated with acute allograft rejection in liver transplantation

    Author: Ke Zhang, Yan-Ling Sun, Shuang-Nan Zhou, Ruo-Nan Xu, Zhen-Wen Liu, Fu-Sheng Wang, Ming Shi
    Journal: IMMUNOLOGY LETTERS, 2019, Vol., , DOI:10.1016/j.imlet.2019.03.003
        DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    NATURE REVIEWS DRUG DISCOVERY289137.40
    LANCET700148.10
    NEW ENGLAND JOURNAL OF MEDICINE933145.40
    BMJ-British Medical Journal019.90
    BMJ-British Medical Journal019.90
    Nature Reviews Clinical Oncology12799.40
    Nature Reviews Disease Primers4876.70
    NATURE REVIEWS CANCER396111.90
    NATURE REVIEWS IMMUNOLOGY35193.40
    同分区等级的其他期刊名称 h-index CiteScore
    Energy Material Advances013.80
    Journal of High Energy Astrophysics119.70
    VIEW012.60
    HARVARD BUSINESS REVIEW01.40
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE1086.90
    ACM Transactions on Intelligent Systems and Technology469.30
    Journal of the American Nutrition Association02.50
    TRANSACTIONS OF TIANJIN UNIVERSITY012.50
    Machine Intelligence Research06.70
    Molecular Biomedicine06.30
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

同领域作者分享投稿经验:共34


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室